NAYA Biosciences completed the merger with INVO Bioscience.

NAYA Biosciences, an agile and synergistic platform, completed the merger with INVO Bioscience, a medical device company providing devices and products for infertility diagnosis. Financial terms were not disclosed. “We are confident that our expanded portfolio business model and combined assets have the potential to create significant value for both legacy and new shareholders. Combining scalable, profitable revenues from our fertility business with the upside of innovative therapeutics optimizes risk-return for investors. In addition, the hub-and-spoke model allows for shared resources and talent to accelerate the development of our lean, agile subsidiaries,” Steve Shum.